Patent · US Active

Short term treatment for uterine disorder

US7875036B2 · kind B2 · utility

8Cited by
109References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 24, 2005
Grant dateJan 25, 2011
Priority date
Expiry dateJun 17, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B17/282
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A method and device for treating a female patient's uterine disorder by occluding one or both of the patient's uterine artery. The treatment involves occluding one or both of the patient's uterine arteries with an intravaginal device to form a thrombus within the occluded artery or arteries and administering an agent which will prolong the occlusion of the artery or arteries after removal of the occluding device or initiate or accelerate fibroid cell apoptosis (programmed cell death). The intravaginal device has a pair of pivotally connected occluding members, with at least one of the occluding member having a movable occluding element on a distal shaft section of the occluding member.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.